2022
Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer
Gelissen JH, Huang GS. Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer. Frontiers In Oncology 2022, 12: 914405. PMID: 36052252, PMCID: PMC9424890, DOI: 10.3389/fonc.2022.914405.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsEpithelial-mesenchymal transitionEndometrial cancerMesenchymal transitionRegulation of EMTTherapeutic interventionsInvasive capacityCancer metastasisEpithelial originEndocrine pathwaysMesenchymal phenotypeCancerCancer cellsEndocrine signalingMetastasisSignaling pathwaysCritical regulatorMortalityPathwayPotential avenues
2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds
Amin ARMR, Karpowicz PA, Carey TE, Arbiser J, Nahta R, Chen ZG, Dong JT, Kucuk O, Khan GN, Huang GS, Mi S, Lee HY, Reichrath J, Honoki K, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bhakta D, Halicka D, Niccolai E, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Bilsland A, Shin DM. Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Seminars In Cancer Biology 2015, 35: s55-s77. PMID: 25749195, PMCID: PMC4561219, DOI: 10.1016/j.semcancer.2015.02.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsCarcinogenesisCell ProliferationDNA-Binding ProteinsGrowth Differentiation Factor 15Hippo Signaling PathwayHumansKruppel-Like Transcription FactorsMolecular Targeted TherapyNeoplasmsNuclear ProteinsProtein Serine-Threonine KinasesPTEN PhosphohydrolaseRetinoblastoma ProteinSignal TransductionSomatomedinsTranscription FactorsTumor Suppressor Protein p53ConceptsInsulin-like growth factorGrowth signalingCancer cellsGrowth differentiation factor 15Cell growthSuppression of genesActivation of genesDifferentiation factor 15AT-rich interactive domain 1ASignaling processesRetinoblastoma proteinFactor 15Tensin homologRb pathwayClinical settingSignalingGrowth factorAdverse effectsDomain 1AMolecular targetsPotential targetPathwayHippoGenesImportant pathway
2011
Downregulation of Filamin A Interacting Protein 1-Like is Associated with Promoter Methylation and Induces an Invasive Phenotype in Ovarian Cancer
Burton ER, Gaffar A, Lee SJ, Adeshuko F, Whitney KD, Chung JY, Hewitt SM, Huang GS, Goldberg GL, Libutti SK, Kwon M. Downregulation of Filamin A Interacting Protein 1-Like is Associated with Promoter Methylation and Induces an Invasive Phenotype in Ovarian Cancer. Molecular Cancer Research 2011, 9: 1126-1138. PMID: 21693594, PMCID: PMC3157597, DOI: 10.1158/1541-7786.mcr-11-0162.Peer-Reviewed Original ResearchMeSH KeywordsCarrier ProteinsCell LineCell Line, TumorCell MovementCell ProliferationCpG IslandsCyclic AMP Response Element-Binding ProteinCytoskeletal ProteinsDNA MethylationFemaleGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessNeoplasm StagingOvarian NeoplasmsPhenotypePromoter Regions, GeneticConceptsOvarian cancer cellsFILIP1L expressionOvarian cancerCAMP-responsive element binding proteinCancer cellsClinical ovarian cancer specimensFive-year survival rateMore effective therapeutic interventionsInvasive phenotypeLethal gynecologic malignancyOvarian cancer cell linesNormal ovarian epithelial cellsOvarian cancer specimensOvarian cancer invasionOvarian cancer therapyEffective therapeutic interventionsCell linesOvarian epithelial cellsOvarian cell linesCancer cell linesGynecologic malignanciesOvarian specimensCancer specimensStage IIIDNA demethylating agent